ATE40946T1 - Arzneimittel oder prophylaktisches mittel zur behandlung von epilepsie. - Google Patents
Arzneimittel oder prophylaktisches mittel zur behandlung von epilepsie.Info
- Publication number
- ATE40946T1 ATE40946T1 AT84102485T AT84102485T ATE40946T1 AT E40946 T1 ATE40946 T1 AT E40946T1 AT 84102485 T AT84102485 T AT 84102485T AT 84102485 T AT84102485 T AT 84102485T AT E40946 T1 ATE40946 T1 AT E40946T1
- Authority
- AT
- Austria
- Prior art keywords
- prophylactic agent
- epilepsy
- medicinal
- treatment
- remedial
- Prior art date
Links
- 230000000069 prophylactic effect Effects 0.000 title abstract 2
- 206010015037 epilepsy Diseases 0.000 title 1
- 206010010904 Convulsion Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 abstract 1
- 235000017471 coenzyme Q10 Nutrition 0.000 abstract 1
- 230000000246 remedial effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP58036568A JPS59163316A (ja) | 1983-03-08 | 1983-03-08 | けいれんの治療・予防剤 |
EP84102485A EP0118132B1 (en) | 1983-03-08 | 1984-03-08 | A remedial or prophylactic agent for the treatment of seizures |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE40946T1 true ATE40946T1 (de) | 1989-03-15 |
Family
ID=12473362
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT84102485T ATE40946T1 (de) | 1983-03-08 | 1984-03-08 | Arzneimittel oder prophylaktisches mittel zur behandlung von epilepsie. |
Country Status (5)
Country | Link |
---|---|
US (1) | US4491594A (en]) |
EP (1) | EP0118132B1 (en]) |
JP (1) | JPS59163316A (en]) |
AT (1) | ATE40946T1 (en]) |
DE (1) | DE3476847D1 (en]) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61221131A (ja) * | 1985-03-28 | 1986-10-01 | Eisai Co Ltd | 吸収促進したユビデカレノン含有組成物 |
US4885167A (en) * | 1985-04-19 | 1989-12-05 | Board Of Regents, The University Of Texas System | Restoration of impaired cardiac function of patients with diverse muscular dystrophies by therapy with coenzyme Q10 |
US6461593B1 (en) * | 1992-02-19 | 2002-10-08 | Biomedical And Clinical Research | Therapy with coenzyme Q10 to reduce subgingival microorganisms in patients with periodontal disease |
US5343512A (en) * | 1992-03-27 | 1994-08-30 | Motorola, Inc. | Call setup method for use with a network having mobile end users |
JP3859699B2 (ja) * | 1992-05-28 | 2006-12-20 | センター・フォー・モレキュラー・バイオロジー・アンド・メディシン | 治療用組成物 |
CN100391447C (zh) * | 2004-01-15 | 2008-06-04 | 范敏华 | 一种辅酶q10冻干粉针剂及其制备方法 |
US20060111743A1 (en) * | 2004-11-19 | 2006-05-25 | Gurney Harry C Jr | Method for arresting seizure activity |
ES2619303T3 (es) * | 2005-06-01 | 2017-06-26 | Edison Pharmaceuticals, Inc. | Productos terapéuticos redox activos para el tratamiento de enfermedades mitocondriales y otras afecciones y modulación de biomarcadores energéticos |
US7838526B2 (en) * | 2005-08-05 | 2010-11-23 | Esther Baldinger | Method of treating neurological disorders |
EA021818B1 (ru) * | 2005-09-15 | 2015-09-30 | Эдисон Фармасьютикалз, Инк. | Варианты хвостовой части редокс-активных лекарственных средств для лечения митохондриальных болезней и модуляция биомаркера энергетического обмена q10 |
CA2635280C (en) | 2006-02-22 | 2017-12-12 | Edison Pharmaceuticals, Inc. | Side chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers |
EP2344142B1 (en) | 2008-09-10 | 2024-06-26 | PTC Therapeutics, Inc. | Treatment of pervasive developmental disorders with redox-active therapeutics |
MX391378B (es) | 2015-12-17 | 2025-03-21 | Ptc Therapeutics Inc | Derivados de fluoroalquil-, fluoroalcoxi-, fenoxi-, heteroariloxi-, alcoxi- y amina-1,4-benzoquinona para tratamiento de trastornos de estres oxidativo. |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3534137A (en) * | 1965-09-30 | 1970-10-13 | Takeda Chemical Industries Ltd | Method of systemic therapy for severe early destructive periodontal disease |
US3452144A (en) * | 1966-03-26 | 1969-06-24 | Takeda Chemical Industries Ltd | Method for treatment of congestive heart failure with coenzyme qn |
JPS5845403B2 (ja) * | 1976-02-14 | 1983-10-08 | エーザイ株式会社 | 補酵素qを主成分とする膵機能亢進剤 |
JPS5942649B2 (ja) * | 1976-02-14 | 1984-10-16 | エーザイ株式会社 | 重症筋無力症治療剤 |
JPS5938202B2 (ja) * | 1976-03-05 | 1984-09-14 | エーザイ株式会社 | 難聴治療剤 |
-
1983
- 1983-03-08 JP JP58036568A patent/JPS59163316A/ja active Granted
-
1984
- 1984-03-02 US US06/585,805 patent/US4491594A/en not_active Expired - Fee Related
- 1984-03-08 AT AT84102485T patent/ATE40946T1/de not_active IP Right Cessation
- 1984-03-08 DE DE8484102485T patent/DE3476847D1/de not_active Expired
- 1984-03-08 EP EP84102485A patent/EP0118132B1/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
EP0118132A2 (en) | 1984-09-12 |
JPS59163316A (ja) | 1984-09-14 |
US4491594A (en) | 1985-01-01 |
EP0118132B1 (en) | 1989-03-01 |
EP0118132A3 (en) | 1985-11-06 |
DE3476847D1 (en) | 1989-04-06 |
JPH0133082B2 (en]) | 1989-07-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY100343A (en) | Amide derivative and external medicament comprising same | |
CA1273019C (en) | ENKEPHALINASE INHIBITORS | |
FR2416012A1 (fr) | Derives de l'imidazole et medicament contenant ces substances | |
ATE73331T1 (de) | Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus. | |
ATE226014T1 (de) | Prophylaktische behandlung der allergischen kontaktdermatitis | |
ATE40946T1 (de) | Arzneimittel oder prophylaktisches mittel zur behandlung von epilepsie. | |
ATE12729T1 (de) | Haarbehandlungsmittel. | |
HRP920667A2 (en) | Application of fultripine active substance for preventing muscle deformation | |
ATE231837T1 (de) | Hydroxamsäure- und carbonsäurederivate mit mmp und tnf hemmender wirkung | |
ATE201597T1 (de) | Verabreichung von riluzol zur behandlung von neuro-aids | |
DE69713620D1 (de) | Verwendung von arachidonsäure und/oder docohexaensäure zur herstellung eines arzneimittels zur behandlung von dyspraxia | |
DK0736029T3 (da) | Antikonvulsive pseudofructopyranosesulfamater | |
EP1274414A4 (en) | NASAL ADMINISTRATION OF AGENTS TO TREAT GASTROPARESIA | |
ES8607916A1 (es) | Un procedimiento para la preparacion de medicamentos influenciadores de la circulacion sanguinea, que contienen compuestos de bis (carboxamida) | |
NZ299727A (en) | Preparation of valproic acid analogues and its use for treatment of epilepsy | |
IE43396L (en) | Oxazolidinones | |
DE69127713D1 (de) | Behandlung von Abgasen, die Silikon- und/oder Phosphorverbindungen enthalten | |
DE69314463D1 (de) | Hautregenerierende kosmetische zusammensetzung | |
ATE157660T1 (de) | Hydroxymethylfurazancarbonsäurederivate und ihre verwendung in der behandlung von kardiovaskulären erkrankungen | |
KR880007070A (ko) | 백내장 치료용 약학 조성물 | |
SE7702130L (sv) | Forfarande for framstellning av n-(merkaptoacyl)-histidiner | |
ES460621A1 (es) | Procedimiento de sintesis de n-(1'-alil-2'-pirrolidilmetil)-2,3-dimetoxi-5-sulfamoilbenzamida. | |
ATE167399T1 (de) | Verwendung von sulfasalazin und/oder dessen aktiven metaboliten zur herstellung eines arzneimittels zur behandlung von venöser insuffizienz und venösen ulcera | |
YU17999A (sh) | Novi derivati pentaeritrita, njihova izrada i primena kao i međuproizvodi za njihovu sintezu | |
FR2355846A1 (fr) | Esters de penicillines utilisables comme medicaments |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |